Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
ABVC BioPharma, Inc. (ABVC)
NASDAQ:ABVC
ABVC BioPharma, Inc. (ABVC) Stock Price & Analysis
20 Followers
ABVC Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.50 - $3.13
Previous Close$0.6
Volume18.20K
Average Volume (3M)869.66K
Market Cap
$21.83M
Enterprise Value$21.39M
Total Cash (Recent Filing)$1.40M
Total Debt (Recent Filing)$3.11M
Price to Earnings (P/E)-1.5
Beta1.18
Next Earnings
Mar 30, 2023EPS Estimate
-$0.15Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.39
Shares Outstanding32,632,329
10 Day Avg. Volume26,008
30 Day Avg. Volume869,664
Standard Deviation0.20
R-Squared0.01
Alpha-0.05
Financial Highlights & Ratios
Price to Book (P/B)3.36
Price to Sales (P/S)51.42
Price to Cash Flow (P/CF)3472528.50
P/FCF Ratio-2.30
Enterprise Value/Market CapN/A
Enterprise Value/Revenue62.37
Enterprise Value/Gross Profit61.00
Enterprise Value/Ebitda-1.21
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
ABVC BioPharma, Inc. News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ABVC FAQ
What was ABVC BioPharma, Inc.’s price range in the past 12 months?
ABVC BioPharma, Inc. lowest stock price was $0.50 and its highest was $3.13 in the past 12 months.
What is ABVC BioPharma, Inc.’s market cap?
Currently, no data Available
When is ABVC BioPharma, Inc.’s upcoming earnings report date?
ABVC BioPharma, Inc.’s upcoming earnings report date is Mar 30, 2023 which is tomorrow.
How were ABVC BioPharma, Inc.’s earnings last quarter?
ABVC BioPharma, Inc. released its earnings results on Nov 14, 2022. The company reported -$0.11 earnings per share for the quarter, beating the consensus estimate of -$0.2 by $0.09.
Is ABVC BioPharma, Inc. overvalued?
According to Wall Street analysts ABVC BioPharma, Inc.’s price is currently Overvalued.
Does ABVC BioPharma, Inc. pay dividends?
ABVC BioPharma, Inc. does not currently pay dividends.
What is ABVC BioPharma, Inc.’s EPS estimate?
ABVC BioPharma, Inc.’s EPS estimate is -$0.15.
How many shares outstanding does ABVC BioPharma, Inc. have?
ABVC BioPharma, Inc. has 32,632,328 shares outstanding.
What happened to ABVC BioPharma, Inc.’s price movement after its last earnings report?
ABVC BioPharma, Inc. reported an EPS of -$0.11 in its last earnings report, beating expectations of -$0.2. Following the earnings report the stock price went down -4%.
Which hedge fund is a major shareholder of ABVC BioPharma, Inc.?
Currently, no hedge funds are holding shares in ABVC
---
ABVC BioPharma, Inc. Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-75.95%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-18.72%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
ABVC BioPharma, Inc.
American BriVision (Holding) Corp. is a clinical stage biopharmaceutical company, which focuses on the development of new drugs and medical devices. The company also integrates research achievements from Memorial Sloan Kettering Cancer Center and MD Anderson Cancer Center. It conducts clinical trials of translational medicine for Proof of Concept and out-licenses it to international pharmaceutical companies. Its products include BLI-1005 CNS-Major Depressive Disorder; BLI-1008 CNS-Attention Deficit Hyperactivity Disorder; BLI-1401-1 Anti-Tumor Combination Therapy-Solid Tumor with Anti-PD-1; BLI-1401-2 Anti-Tumor Combination Therapy-Triple Negative Breast Cancer; and BLI-1501 Hematology-Chronic Lymphocytic Leukemia. The company was founded in 1990 and is headquartered in Fremont, CA.
---
Top 5 ETFs holding ABVC
Currently, no data available
Please return soon. This page is being updated.
Up to five ETFs with an Outperform Smart Score that hold ABVC. The ETFs are listed according to market value of ABVC within the ETF
---
Spruce Biosciences
―
Codiak BioSciences
―
Inhibitor Therapeutics
―
Marker Therapeutics
―
Soligenix
―
---